When the Healer Becomes the Patient: Fentanyl, Professional Addiction, and Systemic Vulnerabilities in a Romanian Teaching Hospital – A Critical Analysis of the Floreasca Case – Fentanyl diversion and physician addiction in Romania

Description

Author:
psychologist Eusebiu Jean Tihan, M.Sc.

Tihan & Associates. Professional Civil Society for Psychology,

Psychologist researcher Bucharest, Romania;
https://orcid.org/0009-0008-8316-3679;

Email: eusebiu.tihan@gmail.com

Tihan, Eusebiu Jean, ”When the Healer Becomes the Patient: Fentanyl, Professional Addiction, and Systemic Vulnerabilities in a Romanian Teaching Hospital –  A Critical Analysis of the Floreasca Case – Fentanyl diversion and physician addiction in Romania”, în Index Academic, II 2026, DOI: 10.58679/IA66206, https://www.indexacademic.ro/en/pdf/when-the-healer-becomes-the-patient/

© 2026 Eusebiu Jean TIHAN. Responsabilitatea conținutului, interpretărilor și opiniilor exprimate revine exclusiv autorilor.

Conflict of interest: None.

Funding: None

Acknowledgments: The author thank the investigative journalism teams and the medical staff who publicly highlighted the system’s vulnerabilities.

Abstract

Background: In June 2026, a fifth-year resident physician was found deceased in a restroom of the Floreasca Emergency Clinical Hospital in Bucharest, Romania. Media sources citing judicial leaks hypothesized self-administration of fentanyl as the cause of death, but no official medico-legal report has been published.

Objective: To critically analyze four operational questions: (1) Does Romania maintain a national registry or public list of physicians with fentanyl use disorder? (2) What are the plausible sources of procurement for such substances? (3) Does this case expose systemic vulnerabilities in the hospital’s controlled substance accountability? (4) Does personal consumption necessarily imply diversion from patients’ therapeutic schemes?

Methods: We performed a critical synthesis of publicly available information (press releases, official hospital statements, judicial hypotheses) combined with international peer-reviewed literature on drug diversion in anesthesia, prevalence of substance use disorder among anesthesiology residents, and systemic risk factors for opioid diversion.

Results: (1) No national registry or public list exists in Romania. International data indicate an incidence of 2.87 substance use disorder cases per 1,000 anesthesia residency-years, with fentanyl and sufentanil being the most commonly diverted opioids. (2) Three procurement scenarios are theoretically possible: diversion from hospital stock, falsification of waste disposal records, or external sources (illicit market, forged prescriptions). The hospital management denies any stock discrepancy, but the investigation is ongoing. (3) Vulnerability must be differentiated as individual (circumvention of procedures) versus systemic (incomplete logs, lack of automated reconciliation, rare audits). No systemic breach has been demonstrated at Floreasca Hospital to date. (4) Personal consumption does not automatically equate to patient deprivation – three distinct mechanisms exist, and the final forensic report is required to determine which applies.

Conclusions: The Floreasca case exposes a blind spot in Romanian public health policy: the absence of a professional monitoring system for physician substance use disorders, the lack of confidential mental health support for overworked residents, and the need for a national protocol on opioid diversion prevention in hospitals. Until the final medico-legal report is published, all assertions regarding fentanyl remain hypotheses – not established facts.

Keywords: fentanyl, drug diversion, physician impairment, substance use disorder, anesthesia residency, patient safety, Romania.

Când tămăduitorul devine pacient: Fentanil, dependență profesională și vulnerabilități sistemice într-un spital universitar românesc – O analiză critică a cazului Floreasca – Diversiune de fentanil și dependență la medici în România

Rezumat

Context: În iunie 2026, un medic rezident în anul V a fost găsit decedat într-o toaletă a Spitalului Clinic de Urgență Floreasca din București, România. Sursele media care citează scurgeri de informații judiciare au emis ipoteza auto-administrării de fentanil ca fiind cauza decesului, dar niciun raport medico-legal oficial nu a fost publicat.

Obiectiv: Analizarea critică a patru întrebări operaționale: (1) România deține un registru național sau o listă publică a medicilor cu tulburare de consum de fentanil? (2) Care sunt sursele plauzibile de procurare a unor astfel de substanțe? (3) Acest caz expune vulnerabilități sistemice în sistemul de evidență a substanțelor controlate din spital? (4) Consumul personal implică în mod necesar sustragerea din schemele terapeutice ale pacienților?

Metode: Am realizat o sinteză critică a informațiilor disponibile public (comunicate de presă, declarații oficiale ale spitalului, ipoteze judiciare), combinată cu literatura internațională evaluată de colegi privind diversiunea de medicamente în anestezie, prevalența tulburării de consum de substanțe în rândul rezidenților de anesteziologie și factorii de risc sistemici pentru diversiunea de opioide.

Rezultate: (1) Nu există un registru național sau o listă publică în România. Datele internaționale indică o incidență de 2,87 cazuri de tulburare de consum de substanțe la 1.000 de ani-rezidențiat în anestezie, fentanilul și sufentanilul fiind opioidele cele mai frecvent sustrase. (2) Trei scenarii de procurare sunt teoretic posibile: diversiune din stocul spitalului, falsificarea înregistrărilor de eliminare a resturilor sau surse externe (piața ilegală, rețete falsificate). Conducerea spitalului neagă orice discrepanță de stoc, dar ancheta este în desfășurare. (3) Vulnerabilitatea trebuie diferențiată ca fiind individuală (ocolirea procedurilor) versus sistemică (registre incomplete, lipsa reconcilierii automate, audituri rare). Până în prezent, nu a fost demonstrată nicio breșă sistemică la Spitalul Floreasca. (4) Consumul personal nu echivalează automat cu lipsirea pacienților – există trei mecanisme distincte, iar raportul medico-legal final este necesar pentru a determina care se aplică.

Concluzii: Cazul Floreasca expune un punct orb în politica românească de sănătate publică: absența unui sistem profesionist de monitorizare a tulburărilor de consum de substanțe în rândul medicilor, lipsa unui sprijin confidențial pentru sănătatea mintală a rezidenților suprasolicitați și necesitatea unui protocol național privind prevenirea diversiunii de opioide în spitale. Până la publicarea raportului medico-legal final, toate afirmațiile privind fentanilul rămân ipoteze – nu fapte stabilite.

Cuvinte cheie: fentanil, diversiune de medicamente, deficiență profesională a medicului, tulburare de consum de substanțe, rezidențiat anestezie, siguranța pacientului, România.

1. INTRODUCTION

On June 6, 2026, a 32-year-old fifth-year resident physician, Alexandru Neacșu, was found unconscious in a restroom of the Floreasca Emergency Clinical Hospital in Bucharest, Romania. Despite resuscitation attempts by colleagues, he was pronounced dead. Media sources citing judicial leaks reported that preliminary necropsy findings suggested self-administration of fentanyl – a synthetic opioid 50–100 times more potent than morphine, legally used in anesthesia and severe pain management (Adevărul, 2026; News.ro, 2026).

However, several key facts remain unconfirmed:

• The final medico-legal report has not been published.
• The hospital’s management has publicly stated that no fentanyl vials are missing from the controlled substance inventory.
• The resident was not an anesthesia specialist (he was in his final year of a non-anesthesia residency, though details of his exact specialization were not disclosed).

This case has sparked a public debate in Romania about physician addiction, access to controlled substances, and systemic accountability. Our objective is to move beyond sensational headlines and provide a scientifically grounded analysis of four operational questions that are relevant to any hospital system.

2. METHODS

We conducted a critical synthesis of two categories of sources:

1. Publicly available information on the Floreasca case – including press articles from Adevărul, News.ro, official statements from the hospital manager (Bogdan Zidaru), the head of the ATI department (Prof. Dr. Cătălina Poiana), and the Multidisciplinary Society of Resident Physicians.
2. Peer-reviewed literature – focusing on systematic reviews and cohort studies regarding substance use disorder (SUD) among anesthesiology residents, drug diversion patterns, and prevention programs. Key search terms: “fentanyl diversion anesthesia”, “physician substance use disorder incidence”, “drug diversion detection hospital”.

We explicitly acknowledge the limitation that the judicial investigation is ongoing. Therefore, our analysis is probabilistic and scenario-based, not deterministic.

3. RESULTS

3.1. Is there a national registry or public list of physicians with fentanyl use disorder in Romania?

No. To our knowledge, Romania has no public national registry of physicians diagnosed with substance use disorder, nor any specialty-specific tracking of fentanyl-related impairment. This is consistent with many European countries, but contrasts with some US state physician health programs (PHPs) that maintain confidential monitoring (Berge et al., 2009).

International context: Data from the American Society of Anesthesiologists (ASA) and peer-reviewed studies indicate:

• An incidence of 2.87 cases of SUD per 1,000 anesthesia residency-years (Warner et al., 2013).
• Among anesthesiology residents with SUD, fentanyl and sufentanil are the most commonly diverted opioids (Bryson & Silverstein, 2008).
• Mortality rates are significant: a retrospective study found that 6% of anesthesiology residents with SUD died during follow-up (Collins et al., 1999).

Thus, while Romania lacks local statistics, the international evidence establishes that anesthesia residents are a high-risk group for fentanyl-related SUD.

3.2. What are the plausible sources of fentanyl procurement in such cases?

Based on the literature on drug diversion in healthcare settings (Berge et al., 2012; McGreevy et al., 2013), we identify three principal scenarios:

In the Floreasca case:

• The hospital manager stated that no fentanyl is missing from the controlled substance inventory.
• If this is accurate and complete (which requires independent audit), then Scenarios A and B become less plausible, and Scenario C becomes more likely.
• However, without access to the investigation file, we cannot rule out incomplete logkeeping or delayed detection.

3.3. Does this case reveal systemic vulnerability in controlled substance accountability?

This question requires distinguishing between individual and systemic vulnerability.

• Individual vulnerability: Even well-designed systems can be circumvented by a determined individual. Single-signature logs, lack of video surveillance in medication rooms, and reliance on self-reporting of waste disposal create opportunities.
• Systemic vulnerability: Refers to predictable, repeatable failures – e.g., no regular reconciliation between dispensed and administered doses, no automated alerts for unusual wastage patterns, no random audits.

What we know about Floreasca (publicly):

• The hospital has a system where only the chief physician on duty holds the key to the controlled substance storage.
• No public information exists about routine audits or waste reconciliation frequency.

Conclusion: The case highlights potential vulnerabilities, but does not, in itself, prove a systemic breach. The final investigation will determine whether there was a failure of individual circumvention (which exists in any system) or a systemic weakness (which requires policy change).

3.4. Does personal fentanyl consumption imply diversion from patients?

No, not automatically. As shown in Table 1 above, personal consumption can occur without any patient being deprived of analgesia (Scenarios B and C). This is a crucial distinction often lost in media coverage.

However, if the source is internal hospital stock and if the resident was not authorized to access fentanyl for any legitimate purpose (e.g., he was not an anesthesiologist nor working in a unit where fentanyl is routinely used), then diversion necessarily occurred – but not necessarily from a specific patient’s dose (it could be from waste or from stock designated for future use).

4. DISCUSSION

4.1. The Romanian context: absence of preventive infrastructure

The Floreasca case is not an isolated reminder. Resident physicians in Romania have repeatedly reported burnout, excessive on-call hours, and lack of confidential mental health support (Societatea Multidisciplinară a Medicilor Rezidenți, 2026 statement). The combination of high stress + easy access to potent opioids is a classic risk factor for SUD.

What Romania lacks compared to some Western systems:

• Physician Health Programs (PHPs) – confidential, non-punitive pathways for self-referral of impaired physicians.
• Mandatory education on drug diversion and self-monitoring during residency.
• Random drug testing for physicians in safety-sensitive positions (controversial, but used in some US anesthesia departments).
• Automated controlled substance reconciliation systems (e.g., barcode scanning of every dose administered, with automatic discrepancy alerts).

4.2. Ethical implications: blame vs. prevention

The public discourse in Romania has oscillated between blaming the individual (character weakness) and blaming the system (lack of support). A scientific perspective suggests both are relevant:

• The individual bears responsibility for illegal procurement (if sourced externally) or violation of protocols (if sourced internally).
• The system bears responsibility for failing to provide early detection, confidential help, and a safety culture where asking for help does not end a career.

4.3. Limitations of this analysis

• The investigation is incomplete; final toxicology and forensic pathology reports are pending.
• The hospital’s statement about “no missing fentanyl” has not been independently verified by a third-party audit.
• No Romanian epidemiological data on physician SUD exist; we rely on international extrapolations.

CONCLUSIONS

The death of a young physician at Floreasca Hospital is a tragedy that should prompt structural change, not just individual lamentation. Based on our analysis:

1. No national registry or public list of physicians with fentanyl use disorder exists in Romania.
2. Three procurement scenarios are possible; the hospital denies stock discrepancies, favoring external sourcing, but the final investigation is required.
3. Vulnerability is both individual and systemic – the case highlights the need for better monitoring, but does not, alone, prove a systemic breach.
4. Personal fentanyl use does not automatically equate to patient deprivation – this is an empirical question, not a definitional one.

Recommendations for Romanian health authorities:

• Establish a confidential Physician Health Program for voluntary self-referral.
• Mandate annual diversion prevention training for all residents in specialties with opioid access.
• Implement random, unannounced audits of controlled substance logs in high-risk departments (anesthesia, emergency, ICU, pain clinic).
• Commission a national epidemiological study on the prevalence of SUD among Romanian physicians.

Until the final medico-legal report is published, all assertions about fentanyl in this case remain hypotheses – not established facts. Scientific rigor demands that we distinguish between what is known, what is alleged, and what is possible.

REFERENCES

1. Adevărul. (2026, June 8). Medicul rezident găsit mort în Spitalul Floreasca și-ar fi administrat fentanil [The resident physician found dead at Floreasca Hospital allegedly administered fentanyl to himself]. [Romanian].
   https://adevarul.ro/stiri-interne/evenimente/medicul-rezident-gasit-mort-in-spitalul-floreasca-2535038.html
2. Berge, K. H., Dillon, K. R., Sikkink, K. M., Taylor, T. K., & Lanier, W. L. (2012). Diversion of drugs within health care facilities. Anesthesiology, 116(3), 698–711.
3. Bryson, E. O., & Silverstein, J. H. (2008). Addiction and substance abuse in anesthesiology. Anesthesiology, 109(5), 905–917.
4. Collins, G. B., McAllister, M. S., Jensen, M., & Gooden, T. A. (1999). Chemical dependency treatment outcomes of residents in anesthesiology. Journal of Addictive Diseases, 18(1), 73–84.
5. News.ro. (2026, June 8). Cătălina Poiana: Nu pot să fac niciun fel de afirmație până când nu văd rezultatele raportului medico-legal [Cătălina Poiana: I cannot make any statement until I see the results of the medico-legal report]. [Romanian].
   https://www.news.ro/social/medic-rezident-mort-la-floreasca-catalina-poiana-nu-pot-sa-fac-niciun-fel-de-afirmatie-pana-cand-nu-vad-rezultatele-raportului-medico-legal-adictii-exista-si-la-medici-si-la-alte-profesii-1922401708222026061922473025
6. Warner, D. O., Berge, K., Sun, H., Harman, A., & Hanson, A. C. (2013). Substance use disorder among anesthesiology residents. Anesthesiology, 119(3), 528–536.